Active Pharmaceutical Ingredient Market - Top Companies and Manufacturers

  • Report ID: 4214
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Active Pharmaceutical Ingredient Landscape

top-features-companies
    • Teva Pharmaceutical Industries Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Abbott Laboratories
    • AbbVie Inc.
    • Mylan N.V.
    • GSK plc
    • Eli Lilli and Company
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Merck & Co. Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Pfizer Inc. acquires U.S. FDA approval along with Myovant for MYFEMBREE, a once-daily treatment for premenopausal women with endometriosis to reduce non-menstrual and menstrual pain. Additionally, both companies are jointly commercializing MYFEMBREE with immediate product availability.

  • Abbott Laboratories to collaborate with WW International, Inc. to integrate WeightWatchers, a weight management program, to provide requisite assistance to people diagnosed with diabetes and improvise their health issues.


Author Credits:  Radhika Pawar


  • Report ID: 4214
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of active pharmaceutical ingredient (API) is estimated at USD 263.19 Billion.

The active pharmaceutical ingredient (API) market size was valued at USD 249.92 Billion in 2023 and is anticipated to cross USD 526.57 Billion by the end of 2036, registering more than 5.9% CAGR during the forecast period i.e., between 2024-2036. The higher prevalence of chronic diseases across the globe and spiking cases of medication errors are estimated to majorly boost the market growth.

North America industry is poised to account for majority revenue share by 2036, driven by higher prevalence of cardiovascular diseases in the region.

Teva Pharmaceutical Industries Ltd., Pfizer Inc., Abbott Laboratories, AbbVie Inc., Mylan N.V., GSK plc, Eli Lilli and Company, Sun Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying